132 related articles for article (PubMed ID: 1314079)
1. Opposite regulation of cAMP concentration in the quail oviduct and the mouse uterus by tamoxifen. Correlation with estrogen-antagonist and estrogen-agonist activity.
Fanidi A; Ahnadi C; Fayard JM; Pageaux JF; Laugier C
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):571-7. PubMed ID: 1314079
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition and the regulation of cyclic AMP by the triphenylethylene anti-estrogen tamoxifen in the quail oviduct.
Fanidi A; Pageaux JF; Courion C; Fayard JM; Laugier C
Biol Cell; 1991; 72(1-2):181-6. PubMed ID: 1661631
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterase activity in the quail oviduct: hormonal regulation and involvement in estrogen-induced growth.
Dumas MY; Fanidi A; Pageaux JF; Courion C; Nemoz G; Prigent AF; Pacheco H; Laugier C
Endocrinology; 1988 Jan; 122(1):165-72. PubMed ID: 2446855
[TBL] [Abstract][Full Text] [Related]
4. Effects of tamoxifen, tamoxifen metabolites, and nafoxidine on adenosine 3',5'-monophosphate phosphodiesterase: correlations with growth inhibitory activities but not estrogen receptor affinities.
Fanidi A; Courion-Guichardaz C; Fayard JM; Pageaux JF; Laugier C
Endocrinology; 1989 Sep; 125(3):1187-93. PubMed ID: 2547579
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen on adenosine 3'5',cyclic monophosphate in quail oviduct: possible involvement in estradiol-activated growth.
Laugier C; Courion C; Pageaux JF; Fanidi A; Dumas MY; Sandoz D; Nemoz G; Prigent AF; Pacheco H
Endocrinology; 1988 Jan; 122(1):158-64. PubMed ID: 2826110
[TBL] [Abstract][Full Text] [Related]
6. Dissociated effects of tamoxifen on growth and on progesterone receptor induction in quail oviduct.
Laugier C; Fanidi A; Dufrene L; Fayard JM; Pageaux JF
Gen Comp Endocrinol; 1991 Sep; 83(3):439-46. PubMed ID: 1936925
[TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide phosphodiesterases in uterine development.
Stancel GM; Thompson WJ; Strada SJ
Mol Cell Endocrinol; 1975 Oct; 3(4):283-95. PubMed ID: 172392
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of calmodulin-dependent and -independent cyclic AMP phosphodiesterases from oviduct by fatty acids.
Laugier C; Zebda N; Fanidi A; Lagarde M; Pageaux F
Biochem Biophys Res Commun; 1991 May; 177(1):324-9. PubMed ID: 1645959
[TBL] [Abstract][Full Text] [Related]
9. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase.
Lam HY
Biochem Biophys Res Commun; 1984 Jan; 118(1):27-32. PubMed ID: 6320825
[TBL] [Abstract][Full Text] [Related]
11. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition by tamoxifen of the effects of estradiol benzoate on lipid metabolism in female quail].
Pageaux JF; Laugier C; Duperray B; Pacheco H; Brard E
Gen Comp Endocrinol; 1980 May; 41(1):115-21. PubMed ID: 7390136
[No Abstract] [Full Text] [Related]
13. Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin.
Rowlands MG; Grimshaw R; Jarman M; Bouhoute A; Leclercq G
Biochem Pharmacol; 1997 Jan; 53(2):241-4. PubMed ID: 9037257
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction: regulation of cAMP concentration in cardiac muscle by calmodulin-dependent cyclic nucleotide phosphodiesterase.
Sharma RK
Mol Cell Biochem; 1995; 149-150():241-7. PubMed ID: 8569735
[TBL] [Abstract][Full Text] [Related]
15. Molecular interaction between cAMP and calcium in calmodulin-dependent cyclic nucleotide phosphodiesterase system.
Sharma RK; Kalra J
Clin Invest Med; 1994 Aug; 17(4):374-82. PubMed ID: 7982300
[TBL] [Abstract][Full Text] [Related]
16. Effect of dexamethasone on adenosine 3',5'-monophosphate content and phosphodiesterase activities in 3T3-L1 adipocytes.
Elks ML; Manganiello VC; Vaughan M
Endocrinology; 1984 Oct; 115(4):1350-6. PubMed ID: 6207010
[TBL] [Abstract][Full Text] [Related]
17. Partial contribution of polyamines to the relaxant effect of 17 alpha-estradiol in rat uterine smooth muscle.
Gutiérrez M; Fernández AI; Revuelta MP; Cantabrana B; Hidalgo A
Gen Pharmacol; 1998 Jan; 30(1):71-7. PubMed ID: 9457484
[TBL] [Abstract][Full Text] [Related]
18. Hormonal regulation of 3',5'-adenosine monophosphate phosphodiesterases in cultured rat granulosa cells.
Conti M; Kasson BG; Hsueh AJ
Endocrinology; 1984 Jun; 114(6):2361-8. PubMed ID: 6202500
[TBL] [Abstract][Full Text] [Related]
19. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
Gardner EA; Thompson WJ; Strada SJ; Stancel GM
Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
[TBL] [Abstract][Full Text] [Related]
20. ICI 182,780 inhibits endogenous estrogen-dependent rat uterine growth and tamoxifen-induced developmental toxicity.
Branham WS; Fishman R; Streck RD; Medlock KL; De George JJ; Sheehan DM
Biol Reprod; 1996 Jan; 54(1):160-7. PubMed ID: 8838013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
